Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Nov 20;5(2):79-83.
doi: 10.1002/iju5.12398. eCollection 2022 Mar.

Testicular metastasis from urothelial carcinoma of the bladder

Affiliations
Case Reports

Testicular metastasis from urothelial carcinoma of the bladder

Eri Fukagawa et al. IJU Case Rep. .

Abstract

Introduction: Reports of urothelial carcinoma with testicular metastasis are limited and the etiology and prognosis remain unclear. We report a rare case of testicular metastasis derived from bladder urothelial carcinoma.

Case presentation: A 68-year-old man presented with gross hematuria and urinary frequency. Cystoscopy demonstrated an 8-cm-sized tumor in the bladder; transurethral resection and magnetic resonance imaging confirmed invasive urothelial carcinoma. Cystoprostatourethrectomy was performed, and the pathological diagnosis was high-grade muscle-invasive urothelial carcinoma. Three years later, the patient noticed a left scrotal mass. Left high orchiectomy was performed, and histopathologic examination of the surgical specimen revealed urothelial carcinoma, confirming testicular metastasis derived from bladder cancer. The patient received chemotherapy with gemcitabine and cisplatin and has survived for 7 years since the initial diagnosis without progression.

Conclusion: Although rare, secondary lesions should be considered for the differential diagnosis of testicular tumors in patients with a history of urothelial carcinoma.

Keywords: bladder cancer; metastasis; testicular tumor; transitional cell carcinoma; urothelial carcinoma.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Fig. 1
Fig. 1
Magnetic resonance imaging. Magnetic resonance image showing an 8‐cm tumor at the posterior wall of the bladder, which suggested possible muscle‐invasive bladder cancer.
Fig. 2
Fig. 2
Computed tomography. Computed tomography showing a mass in the left testicle as well as the right internal‐iliac lymphadenopathy (arrow), suggesting metastatic spread of the bladder cancer.
Fig. 3
Fig. 3
Histology. Specimen of the testis exhibiting urothelial carcinoma infiltration. (a) Hematoxylin and eosin staining, 10× magnification, and (b) 2× magnification. The specimen was positive for (c) Uroplakin3 and (d) GATA3.

Similar articles

Cited by

References

    1. Ferlay J, Ervik M, Lam F et al. Global Cancer Observatory: Cancer Today. International Agency for Research on Cancer, Lyon, France, 2021. [Cited 23 Apr 2021]. Available from URL: https://gco.iarc.fr/today.
    1. SEER*Explorer: An interactive website for SEER cancer statistics. Surveillance Research Program, National Cancer Institute. [Cited 23 Apr 2021.] Available from URL: https://seer.cancer.gov/explorer/.
    1. Binkley WF, Seo IS. Metastatic transitional cell carcinoma of the testis. A case report. Cancer 1984; 54: 575–8. - PubMed
    1. Eisenhauer EA, Therasse P, Bogaerts J et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur. J. Cancer 2009; 45: 228–47. - PubMed
    1. Gonzâlez‐Peramato P, Paniagua R, Nistal M. Secondary testicular tumors. Eur. Urol. 1989; 16: 185–8. - PubMed

Publication types